title: Commentary Re: Botox Article by Berger & Knoll IPH 19(5):243-244 on "The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis".
authors.affiliation: Schulich School of Medicine, University of Western Ontario, London, ON, Canada.
authors.forename: Tony
authors.initials: T
authors.lastname: Zhang
authors.forename: Aleem
authors.initials: A
authors.lastname: Adatia
authors.forename: Wasifa
authors.initials: W
authors.lastname: Zarin
authors.forename: Misha
authors.initials: M
authors.lastname: Moitri
authors.forename: Abi
authors.initials: A
authors.lastname: Vijenthira
authors.forename: Rong
authors.initials: R
authors.lastname: Chu
authors.forename: Lehana
authors.initials: L
authors.lastname: Thabane
authors.forename: Walter F
authors.initials: WF
authors.lastname: Kean
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D009140:Musculoskeletal Diseases / Q000188:drug therapy*; D009141:Musculoskeletal System / Q000187:drug effects*; D010146:Pain / Q000188:drug therapy*
chemical_list: D019274:Botulinum Toxins, Type A
references.citation: Ann Intern Med. 2005 Dec 6;143(11):793-7
references.pmid: 16330790
references.citation: Phys Ther. 2008 Feb;88(2):156-75
references.pmid: 18073267
references.citation: Inflammopharmacology. 2011 Feb;19(1):21-34
references.pmid: 21076878
references.citation: Control Clin Trials. 1996 Feb;17(1):1-12
references.pmid: 8721797